Whistler Conference Centre Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2013
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Tuberculosis: Understanding the Enemy (X8)
Organizer(s) Eric J. Rubin, Sébastien Gagneux and Heran Darwin
March 13—18, 2013
Whistler Conference Centre • Whistler, BC Canada
Abstract Deadline: Nov 13, 2012
Late Abstract Deadline: Dec 11, 2012
Scholarship Deadline: Nov 13, 2012
Early Registration Deadline: Jan 14, 2013
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Joint Meeting:
Host Response in Tuberculosis (X7)
Summary of Meeting:
Despite more than a century of research, tuberculosis (TB) remains one of the leading causes of death in the world. Although drug therapy is available, it remains cumbersome and difficult to administer in areas of the developing world where TB is most prevalent. Moreover, the rise of HIV and consequent marked increase in TB susceptibility and the increasing appearance of drug resistant bacterial strains has made management of infection far more difficult. New approaches to treatment and prevention could have an enormous impact on the disease. This meeting will bring together different disciplines, including microbial genomics and genetics, bacterial physiology, systems biology and drug development, to explore how Mycobacterium tuberculosis is transmitted and causes disease. In addition, the conference will be paired with a concurrent meeting that explores host responses to TB. Together, these two conferences will cover a breadth of TB biology and examine the interface between the host and pathogen. The conference will provide an opportunity for interactions among those from different fields and include many participants from disciplines that would not ordinarily participate in a meeting devoted exclusively to TB. We hope to stimulate new collaborations and introduce novel areas of biology so that the field will be positioned to tackle the many remaining challenges for combating this disease. The meeting will also provide an opportunity to develop and engage the next generation of researchers in the field by including junior and early stage investigators in the meeting format.
View Scholarships/Awards
Despite more than a century of research, tuberculosis (TB) remains one of the leading causes of death in the world. Although drug therapy is available, it remains cumbersome and difficult to administer in areas of the developing world where TB is most prevalent. Moreover, the rise of HIV and consequent marked increase in TB susceptibility and the increasing appearance of drug resistant bacterial strains has made management of infection far more difficult. New approaches to treatment and prevention could have an enormous impact on the disease. This meeting will bring together different disciplines, including microbial genomics and genetics, bacterial physiology, systems biology and drug development, to explore how Mycobacterium tuberculosis is transmitted and causes disease. In addition, the conference will be paired with a concurrent meeting that explores host responses to TB. Together, these two conferences will cover a breadth of TB biology and examine the interface between the host and pathogen. The conference will provide an opportunity for interactions among those from different fields and include many participants from disciplines that would not ordinarily participate in a meeting devoted exclusively to TB. We hope to stimulate new collaborations and introduce novel areas of biology so that the field will be positioned to tackle the many remaining challenges for combating this disease. The meeting will also provide an opportunity to develop and engage the next generation of researchers in the field by including junior and early stage investigators in the meeting format.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
WEDNESDAY, MARCH 13
THURSDAY, MARCH 14
FRIDAY, MARCH 15
SATURDAY, MARCH 16
SUNDAY, MARCH 17
MONDAY, MARCH 18
Conference Program Print | View meeting in 12 hr (am/pm) time
WEDNESDAY, MARCH 13
08:00—11:00
Mycobacterium tuberculosis – From Single Cells to Systems
*
Eric J. Rubin,
Harvard T.H. Chan School of Public Health, USA
Heran Darwin,
New York University School of Medicine, USA
Pedal to the Metal: Copper Resistance in Mycobacterium tuberculosis
Pedal to the Metal: Copper Resistance in Mycobacterium tuberculosis
Bree B. Aldridge,
Tufts University, USA
Short Talk: Back to Basics: Diversity through Growth and Division in Mycobacteria
Short Talk: Back to Basics: Diversity through Growth and Division in Mycobacteria
Veronique Anne Dartois,
Hackensack Meridian Health, USA
Pharmacology: The Fate of TB Drugs from Plasma to Lesions and Single Cells
Pharmacology: The Fate of TB Drugs from Plasma to Lesions and Single Cells
Johnjoe McFadden,
University of Surrey, UK
Systems-Based Metabolic Analysis of Intracellular Growth of the TB bacillus
Systems-Based Metabolic Analysis of Intracellular Growth of the TB bacillus
Dany J. V. Beste,
University of Surrey, UK
Short Talk: 13C Isotopomer Spectral Analysis of Cholesterol Metabolism by Mycobacterium tuberculosis Growing in vitro and within Macrophages
Short Talk: 13C Isotopomer Spectral Analysis of Cholesterol Metabolism by Mycobacterium tuberculosis Growing in vitro and within Macrophages
08:00—11:00
How Do Innate Cells Respond to Mtb (I)
How does the lung respond to infection and how do the phagocyte and bacteria interact?
*
David G. Russell,
Cornell University, USA
Larry S. Schlesinger,
Texas Biomedical Research Institute, USA
Unique Immunoregulatory Factors in the Lung Alveolus during the Early Microbe-Host Encounter
Unique Immunoregulatory Factors in the Lung Alveolus during the Early Microbe-Host Encounter
Helen A. Fletcher,
London School of Hygiene and Tropical Medicine, UK
Correlates of Risk of TB Disease in Infants Vaccinated with BCG
Correlates of Risk of TB Disease in Infants Vaccinated with BCG
Jennifer Philips,
Washington University School of Medicine, USA
EsxH ESCRTs TB to Safety by Arresting Phagosome Maturation
EsxH ESCRTs TB to Safety by Arresting Phagosome Maturation
Ishita Bhattacharya,
Garvan Institute for Medical Research, Australia
Short Talk: The Splice Variant of IL-12Rbeta1: A New Player in the IL-12 Signaling Network
Short Talk: The Splice Variant of IL-12Rbeta1: A New Player in the IL-12 Signaling Network
Cliona M. Ni Cheallaigh,
Trinity College Dublin, Ireland
Short Talk: My-D88 Adapter Like (Mal) Is Required for Effective Macrophage Responses to Mycobacterium tuberculosis
Short Talk: My-D88 Adapter Like (Mal) Is Required for Effective Macrophage Responses to Mycobacterium tuberculosis
Alissa C. Rothchild,
Seattle Children's Research Institute, USA
Short Talk: iNKT Cell Production of GM-CSF Inhibits Growth of Mycobacterium tuberculosis
Short Talk: iNKT Cell Production of GM-CSF Inhibits Growth of Mycobacterium tuberculosis
16:00—17:00
Keynote Address: TB: The Continuing Challenge (Joint)
*
Andrea M. Cooper,
University of Leicester, UK
17:00—19:00
How do Innate Cells Respond to Mtb? (Joint)
Mononuclear phagocytes are recognized as the host cells for Mtb but what do they really do? Neutrophils have been largely ignored as actors in tuberculosis, what do these cells do to contribute to disease?
Carl F. Nathan,
Weill Cornell Medical College, USA
Can Macrophages Be Super-Activated?
Can Macrophages Be Super-Activated?
Anne O'Garra,
Francis Crick Institute, UK
Systems Approach to Understand the Immune Response in Tuberculosis
Systems Approach to Understand the Immune Response in Tuberculosis
David G. Russell,
Cornell University, USA
Chemical and Genetic Perturbation of the Intracellular Survival Strategies of Mycobacterium tuberculosis
Chemical and Genetic Perturbation of the Intracellular Survival Strategies of Mycobacterium tuberculosis
08:00—11:00
Mycobacterial Diversity and Disease
*
Graham F. Hatfull,
University of Pittsburgh, USA
Nico C. Gey van Pittius,
University of Stellenbosch, South Africa
Evolution of the PE and PPE Multi-Gene Families in the Mycobacteria
Evolution of the PE and PPE Multi-Gene Families in the Mycobacteria
Thomas Ioerger,
Texas A&M University, USA
What Comparative Genomics of Mycobacteria can Tell Us about Drug Resistance
What Comparative Genomics of Mycobacteria can Tell Us about Drug Resistance
Jeffery S. Cox,
University of California, Berkeley, USA
The Ubiquitin Ligase PARKIN Is Required for Autophagy and Host Resistance to Intracellular Pathogens
The Ubiquitin Ligase PARKIN Is Required for Autophagy and Host Resistance to Intracellular Pathogens
Basim R.K. Al Shammari,
Imperial College London, UK
Short Talk: Infection of MMP-1 Transgenic Mice with Virulent Mycobacterium tuberculosis Causes Human-Type Lung Pathology
Short Talk: Infection of MMP-1 Transgenic Mice with Virulent Mycobacterium tuberculosis Causes Human-Type Lung Pathology
Mireia Coscolla,
Swiss Tropical and Public Health Institute, Switzerland
Short Talk: Adaptive Evolution in Different Lineages of the Mycobacterium tuberculosis Complex
Short Talk: Adaptive Evolution in Different Lineages of the Mycobacterium tuberculosis Complex
Christophe Guilhot,
Centre National de la Recherche Scientifique, France
Short Talk: Do Polymorphisms in phoPR Explain the Lower Virulence for Humans of africanum and Animal Strains of the Mycobacterium tuberculosis Complex?
Short Talk: Do Polymorphisms in phoPR Explain the Lower Virulence for Humans of africanum and Animal Strains of the Mycobacterium tuberculosis Complex?
08:00—11:00
Acquired Immunity - Beyond the CD4 T Cell/Macrophage Paradigm?
While antigen-specific CD4 T cells are the target of current vaccines, it is not clear that these cells are the best mediators of protective immunity.
Eric G. Pamer,
University of Chicago, USA
Ly6Chi Monocytes and Immune Defense Against Mycobacterium tuberculosis Infection
Ly6Chi Monocytes and Immune Defense Against Mycobacterium tuberculosis Infection
*
Samuel M. Behar,
University of Massachusetts Medical School, USA
CD8+ T Cells and Protective Immunity to Tuberculosis
CD8+ T Cells and Protective Immunity to Tuberculosis
Krishna Vankayalapati,
University of Texas Health Center, USA
Short Talk: A Subpopulation of CD4+CD25+Foxp3+ T-Cells Inhibits Growth of Mycobacterium tuberculosis
Short Talk: A Subpopulation of CD4+CD25+Foxp3+ T-Cells Inhibits Growth of Mycobacterium tuberculosis
Peter L. Andersen,
Statens Serum Institut, Denmark
Vaccine Induced Protection Against TB
Vaccine Induced Protection Against TB
Albanus Moguche,
Seattle Biomed, USA
Short Talk: Intrinsic CXCR5 Expression Is Required to Maintain Antigen Specific CD4 T Cells during Chronic Mycobacterium tuberculosis Infection
Short Talk: Intrinsic CXCR5 Expression Is Required to Maintain Antigen Specific CD4 T Cells during Chronic Mycobacterium tuberculosis Infection
Shabaana Khader,
Washington University School of Medicine, USA
Short Talk: Interleukin-17 Mediates Vaccine-Induced Immunity Against Tuberculosis
Short Talk: Interleukin-17 Mediates Vaccine-Induced Immunity Against Tuberculosis
17:00—19:00
Vaccination Against Mtb (Joint)
The availability of patients in close proximity to high tech tools for analysis of immune responses has resulted in an increase in our understanding of the human response to Mtb infection.
*
Tom H. M. Ottenhoff,
Leiden University Medical Center, Netherlands
Alessandro Sette,
La Jolla Institute for Allergy & Immunology, USA
Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed Against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset
Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed Against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset
Thomas Evans,
TomegaVax, USA
Early Results of Vaccine Trials in Humans
Early Results of Vaccine Trials in Humans
Stefan H. E. Kaufmann,
Max Planck Institute for Infection Biology, Berlin, Germany
Vaccination Against Tuberculosis: Back to Basic Research or Forward with Clinical Trials?
Vaccination Against Tuberculosis: Back to Basic Research or Forward with Clinical Trials?
08:00—11:00
Life and Death in Mycobacteria
*
Jeffery S. Cox,
University of California, Berkeley, USA
Eric J. Rubin,
Harvard T.H. Chan School of Public Health, USA
Mycobacterial Proteins: Here Today, Gone… Some Other Time
Mycobacterial Proteins: Here Today, Gone… Some Other Time
Marie I. Samanovic,
New York University School of Medicine, USA
Short Talk: Proteasomal Regulation of Nitric Oxide Resistance in M. tuberculosis
Short Talk: Proteasomal Regulation of Nitric Oxide Resistance in M. tuberculosis
Graham F. Hatfull,
University of Pittsburgh, USA
Mycobacteriophages and Mycobacterium tuberculosis
Mycobacteriophages and Mycobacterium tuberculosis
Kerstin Williams,
University of Surrey, UK
Short Talk: Global Response of Mycobacteria to Nitrogen Stress
Short Talk: Global Response of Mycobacteria to Nitrogen Stress
08:00—11:00
The Consequences of the Immune Response in the Lung
Cellular responses in the lung start slowly
following challenge with Mtb and the
inflammatory site remains dynamic for the
period of infection. Understanding the
dynamics of the cellular response will allow
for improved intervention.
Denise Kirschner,
University of Michigan, USA
A Systems Biology Approach to Uncovering Mechanisms Governing Host-Mycobacterial Interactions during TB Infection in the Lung and Lymph Nodes
A Systems Biology Approach to Uncovering Mechanisms Governing Host-Mycobacterial Interactions during TB Infection in the Lung and Lymph Nodes
Robert J. Francis,
University of Surrey, UK
Short Talk: Selective ESAT6-Dependent Necrosis of Phosphatidylserine Externalised Neutrophils
Short Talk: Selective ESAT6-Dependent Necrosis of Phosphatidylserine Externalised Neutrophils
Manuela Flórido,
Centenary Institute, Australia
Short Talk: Influenza A Virus Infection Impairs Mycobacteria-Specific T Cell Responses and Mycobacterial Clearance in the Lung during Pulmonary Co-Infection
Short Talk: Influenza A Virus Infection Impairs Mycobacteria-Specific T Cell Responses and Mycobacterial Clearance in the Lung during Pulmonary Co-Infection
Melanie J. Harriff,
Oregon Health & Sciences University/PVAMC, USA
Short Talk: Bronchial Epithelial Cells Take Up Mycobacterium tuberculosis into a Late Endosomal Compartment and Are Highly Efficient at Stimulating IFNgamma Release by CD8+ T Cells
Short Talk: Bronchial Epithelial Cells Take Up Mycobacterium tuberculosis into a Late Endosomal Compartment and Are Highly Efficient at Stimulating IFNgamma Release by CD8+ T Cells
14:30—16:30
Workshop 2: Systems Biology in TB Research
Representation from European and NIH Consortia on Systems Biology of TB
*
Matthias Wilmanns,
European Molecular Biology Laboratory Hamburg, Germany
Matthias T. Ehebauer,
European Molecular Biology Laboratory, Germany
Integrating Structural Biology into Systems Biology: Unexpected Carboxylase Activities in Mycobacteria
Integrating Structural Biology into Systems Biology: Unexpected Carboxylase Activities in Mycobacteria
Vítor Martins dos Santos,
Wageningen University, Netherlands
Systems Approaches to Uncover the Cellular Wiring of Mycobacterium tuberculosis
Systems Approaches to Uncover the Cellular Wiring of Mycobacterium tuberculosis
Wei-Hua Chen,
European Molecular Biology Laboratory, Germany
Transcriptome and Proteome Analyses of Mycobacterium tuberculosis
Transcriptome and Proteome Analyses of Mycobacterium tuberculosis
Christoph Grundner,
Seattle Children's Research Institute, USA
Global Profiling of ATP Binding in M. tuberculosis
Global Profiling of ATP Binding in M. tuberculosis
Kyle Minch,
Intellectual Ventures, USA
A Role for Transcriptionally Silent DNA Binding in Mycobacterium tuberculosis
A Role for Transcriptionally Silent DNA Binding in Mycobacterium tuberculosis
Andrej Trauner,
Harvard School of Public Health, USA
High-Throughput Discovery of Drug Mechanism by Gene Overexpression
High-Throughput Discovery of Drug Mechanism by Gene Overexpression
17:00—19:00
A Global View of Infection (Joint)
Unbiased techniques can highlight novel pathways and mechanisms of disease. This session will address the increased understanding of TB that these approaches have generated.
*
Sébastien Gagneux,
Swiss Tropical and Public Health Institute, Switzerland
Evolutionary Forces in Mycobacterium tuberculosis
Evolutionary Forces in Mycobacterium tuberculosis
Scarlet S. Shell,
Worcester Polytechnic Institute, USA
Short Talk: Widespread mRNA Processing Shapes the Mycobacterium tuberculosis Transcriptome
Short Talk: Widespread mRNA Processing Shapes the Mycobacterium tuberculosis Transcriptome
Tom H. M. Ottenhoff,
Leiden University Medical Center, Netherlands
Short Talk: An Unbiased Genome-Wide Mycobacterium tuberculosis Gene-Expression Approach to Discover New Antigens for Human T Cells that Are Expressed during Pulmonary Infection
Short Talk: An Unbiased Genome-Wide Mycobacterium tuberculosis Gene-Expression Approach to Discover New Antigens for Human T Cells that Are Expressed during Pulmonary Infection
Jean-Laurent Casanova,
Rockefeller University, USA
Toward a Genetic Theory of Infectious Diseases
Toward a Genetic Theory of Infectious Diseases
08:00—11:00
The Bacterial Surface and its Interaction with the Host
*
Sarah M. Fortune,
Harvard TH Chan School of Public Health, USA
Mary Jackson,
Colorado State University, USA
Cell Envelope Glycoconjugates: Metabolism and Interaction with the Host
Cell Envelope Glycoconjugates: Metabolism and Interaction with the Host
Keith M. Derbyshire,
Wadsworth Center, New York State Department of Health, USA
ESX, its Role in Secretion, Sex and Mycobacterial Evolution
ESX, its Role in Secretion, Sex and Mycobacterial Evolution
Michael Niederweis,
University of Alabama at Birmingham, USA
Iron Utilization by M. tuberculosis
Iron Utilization by M. tuberculosis
Christopher S. Ealand,
University of the Witwatersrand, South Africa
Short Talk: The Role of Mycobacterial DD-Carboxypeptidases in Peptidoglycan Remodeling and Turnover
Short Talk: The Role of Mycobacterial DD-Carboxypeptidases in Peptidoglycan Remodeling and Turnover
Ellen Foot Perkowski,
University of North Carolina, USA
Short Talk: Exported In vivo Technology (EXIT) to Identify Mtb Proteins Exported during Infection
Short Talk: Exported In vivo Technology (EXIT) to Identify Mtb Proteins Exported during Infection
Jeppe Mouritsen,
Institute of Molecular Systems Biology, Switzerland
Short Talk: Direct Protein Quantification Reveals that Cholesterol Is a Carbon Source of Mycobacterium tuberculosis during Infection
Short Talk: Direct Protein Quantification Reveals that Cholesterol Is a Carbon Source of Mycobacterium tuberculosis during Infection
08:00—11:15
Tuberculosis and HIV
These two pathogens interact to create devastating effects for human health. What is the future for vaccination and control in areas with high incidence of both.
Robert J. Wilkinson,
University of Cape Town, South Africa
The Heart, Mind and Breath of HIV-Associated Tuberculosis
The Heart, Mind and Breath of HIV-Associated Tuberculosis
*
JoAnne L. Flynn,
University of Pittsburgh School of Medicine, USA
Modeling HIV-TB Immune Interaction in Non-Human Primates
Modeling HIV-TB Immune Interaction in Non-Human Primates
Marcelo Kuroda,
Tulane University, USA
Short Talk: Macrophage Damage by SIV as the Cause of TB Reactivation in the TB/SIV Rhesus Co-Infection Model
Short Talk: Macrophage Damage by SIV as the Cause of TB Reactivation in the TB/SIV Rhesus Co-Infection Model
Daniel L. Barber,
NIAID, National Institutes of Health, USA
Mechanisms of Mycobacteria-Associated Immune Reconstitution Inflammatory Syndrome
Mechanisms of Mycobacteria-Associated Immune Reconstitution Inflammatory Syndrome
Richard A. Koup,
NIAID, National Institutes of Health, USA
HIV-Tuberculosis Interaction
HIV-Tuberculosis Interaction
Tracy R. Rosebrock,
Harvard School of Public Health, USA
Short Talk: Single Cell Analysis Reveals Distinct Effects of HIV on Mycobacterium tuberculosis Survival in Co-Infected and Bystander Macrophages
Short Talk: Single Cell Analysis Reveals Distinct Effects of HIV on Mycobacterium tuberculosis Survival in Co-Infected and Bystander Macrophages
14:30—16:30
Workshop 3: Joint Workshop (Joint)
*
Heran Darwin,
New York University School of Medicine, USA
*
Andrea M. Cooper,
University of Leicester, UK
Jonathan A. G. Cox,
University of Birmingham, UK
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
Allison J. Fay,
Sloan-Kettering Institute, USA
A Nonredundant Essential Role for Mycobacterial DnaK in Native Protein Folding
A Nonredundant Essential Role for Mycobacterial DnaK in Native Protein Folding
Alexandre Gouzy,
ICNRS-University of Toulouse, France
A Novel Amino Acid Permease System for M. tuberculosis Nitrogen Acquisition and Host Colonization
A Novel Amino Acid Permease System for M. tuberculosis Nitrogen Acquisition and Host Colonization
Ludovic P. Desvignes,
New York University School of Medicine, USA
Dynamic Roles of Type I and Type II Interferons in Early Infection with Mycobacterium tuberculosis
Dynamic Roles of Type I and Type II Interferons in Early Infection with Mycobacterium tuberculosis
Katrin D. Mayer-Barber,
NIAID, National Institutes of Health, USA
IL-1 Driven Eicosanoids Mediate Host Resistance to Mycobacterium tuberculosis Infection
IL-1 Driven Eicosanoids Mediate Host Resistance to Mycobacterium tuberculosis Infection
17:00—18:45
Host Susceptibility to Disease (Joint)
What are the factors that allow disease to develop in some exposed individuals and not others?
*
Robert J. Wilkinson,
University of Cape Town, South Africa
Erwin Schurr,
Research Institute of the McGill University Health Centre, Canada
Host Genetic Control of Resistance to Infection with M. tuberculosis
Host Genetic Control of Resistance to Infection with M. tuberculosis
Helen McShane,
Jenner Institute, UK
Boosting BCG with MVA85A – Clinical Trials and Efficacy Data
Boosting BCG with MVA85A – Clinical Trials and Efficacy Data
18:45—19:30
Special Session: Panel Discussion of Results of the Recently Published Efficacy Trial of MVA85A Given as a Boost to BCG in South African Infants
*
Willem A. Hanekom,
Bill & Melinda Gates Foundation, USA
Helen McShane,
Jenner Institute, UK
Mark Hatherill,
University of Cape Town, South Africa
Thomas J. Scriba,
University of Cape Town, South Africa
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
Keystone Symposia thanks our Sponsor for generously supporting this meeting:
|
|
We gratefully acknowledge the generous grant for this conference provided by:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
|
|
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |
